Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Galderma Group AG's Enterprise Value is CHF43,412 Mil.
Galderma Group AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was CHF654 Mil. Therefore, Galderma Group AG's EV-to-EBIT ratio for today is 66.43.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Galderma Group AG's Enterprise Value is CHF43,412 Mil.
Galderma Group AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was CHF914 Mil. Therefore, Galderma Group AG's EV-to-EBITDA ratio for today is 47.52.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Galderma Group AG's Enterprise Value is CHF43,412 Mil.
Galderma Group AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CHF4,217 Mil. Therefore, Galderma Group AG's EV-to-Revenue ratio for today is 10.30.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Galderma Group AG (XSWX:GALD) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Galderma Group AG's current Enterprise Value is CHF43,412 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Galderma Group AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was CHF654 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Galderma Group AG's current Enterprise Value is CHF43,412 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Galderma Group AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was CHF914 Mil.
Galderma Group AG's current Enterprise Value is CHF43,412 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Galderma Group AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CHF4,217 Mil.
Galderma Group AG's current Enterprise Value is CHF43,412 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Galderma Group AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was CHF953 Mil.
Galderma Group AG's current Enterprise Value is CHF43,412 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Galderma Group AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF829 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galderma Group AG Enterprise Value Related Terms
Galderma Group AG Enterprise Value Historical Data
* Premium members only.
The historical data trend for Galderma Group AG's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:GALD vs ZTS, UTHR, VTRS: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galderma Group AG Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Galderma Group AG's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Galderma Group AG's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of CHF43,412 Mil mean?
Galderma Group AG (XSWX:GALD) has a Enterprise Value of CHF43,412 Mil as of Jun. 26, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Galderma Group AG and its competitors.
Is Galderma Group AG's Enterprise Value too high?
Galderma Group AG's current Enterprise Value is CHF43,412 Mil. Overall, Galderma Group AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Enterprise Value compare to ZTS and UTHR?
Galderma Group AG's Enterprise Value of CHF43,412 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Galderma Group AG and its competitors. Galderma Group AG's current Enterprise Value is CHF43,412 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Enterprise Value of CHF43,412 Mil. The current Enterprise Value is CHF43,412 Mil. Galderma Group AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Enterprise Value is CHF43,412 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
15GF Score
Get the complete analysis for XSWX:GALD
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GALD has been successfully added to your 